Be Ahead With Economy And Policy Updates
New Delhi: The National Institute of Pharmaceutical Education and Research (NIPER), Hajipur has signed a Memorandum of Understanding (MoU) with the Indian Pharmacopoeia
New Delhi: Aurobindo Pharma Limited has announced that it has received the final approval from the US Food & Drug Administration (USFDA) to
Bengaluru: Aster DM Healthcare, one of the largest integrated healthcare providers in India, has invested Rs. 96 crore towards the expansion of its
New Jersey: Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration (U.S. FDA) for Progesterone Vaginal
Ahmedabad: Zydus Lifesciences Limited (“Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg
New Delhi: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for
New Jersey: Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced that it will manage end-to-end commercialization and distribution for RYALTRIS® (Olopatadine Hydrochloride and Mometasone
Mumbai: Global pharmaceutical leader, Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval
Midland, Texas, USA: CrudeChem Technology announced the launch of an additional 15 acre operational facility in Midland, Texas, marking a significant milestone in
New Delhi: Torrent Pharmaceuticals today announced the launch of its Semaglutide brands – Sembolic and Semalix – in India, in both oral and
Newsletter
Persistent Wins CII Award for Excellence in Disability Inclusion
Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg
BCPL Railway Infra Bags Rs. 46.18 Million Work Under Sealdah Division of Eastern Railway
Intense Technologies Announces Retirement of Founder C.K. Shastri
ACS Technologies Achieves CMMI Maturity Level 3 Appraisal For DEV and SVC Domains
